Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Emery, Paul
TEEMS, NCT03813771: Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell Stratification	Not yet recruiting	4	106	Europe	Benepali, Etanercept, Sulfasalazine, Methotrexate, Hydroxychloroquine	University of Leeds, Samsung Bioepis Co., Ltd.	Rheumatoid Arthritis	02/23	02/23
NCT02012764: The CCP Study: Coordinated Programme to Prevent Arthritis - Can We Identify Arthritis at a Pre-clinical Stage ?	Recruiting	N/A	4000	Europe		University of Leeds, AbbVie	Inflammatory Arthritis, Rheumatoid Arthritis	06/21	12/21